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Background: Myocarditis complicated with complete atrioventricular block (CAVB) is 
rare in children. The purpose of this study was to report the outcome of myocarditis 
with CAVB in our institution.
Methods: Between June 1998 and June 2007, nine pediatric patients (aged from 
1.5 to 16 years) were admitted, presenting with acute myocarditis with CAVB. We 
analyzed their clinical presentations, biochemistry and serology studies, chest X-rays, 
electrocardiograms, echocardiography, complications and outcomes.
Results: Hypotension and Stokes-Adams seizures occurred in five and four of our 
patients, respectively. Cardiomegaly of chest X-ray was common in eight (89%) of 
our patients. Echocardiography revealed impaired left ventricular performance in 
three patients. Six patients suffered ventricular tachycardia (VT). Three cases of 
VT occurred before pacemaker implantation and the others occurred afterwards. 
Eight patients survived. Six of them regained sinus rhythm within 12 days (range 
1−12 days), and two had a right bundle branch block at follow-up. Two patients had 
persistent CAVB, and one received permanent pacemaker implantation; the other 
received supportive care. One patient died due to persistent low cardiac output and 
a new onset of VT on the 4th admission day. During a follow-up period of 56 ± 27 
months, all eight surviving patients remained asymptomatic.
Conclusions: The outcome of CAVB complicated with myocarditis is variable. Most of 
our patients resumed normal heart function. The incidence of persistent CAVB was 
22%. VT is a common and serious complication, but it can be effectively treated 
medically. Persistent low cardiac output after pacemaker implantation and late onset 
VT should be considered as risk factors of mortality.
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1. Introduction
Myocarditis is an inflammation of the myocardium 
not related to structural heart defects or coronary 
artery anomalies. Clinical manifestations of acute 
myocarditis vary from mild flu-like symptoms with 
barely detectable myocardial dysfunction to the 
fulminate fatal forms of congestive heart failure 
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or cardiogenic shock.1 Of the varied presentations 
of myocarditis, complete atrioventricular block 
(CAVB) was thought to be an isolated feature, with 
rapid and full recovery if it was diagnosed early 
and treated with emergency pacemaker implanta-
tion.2 In the literature, deaths from CAVB leading to 
ventricular arrest have been reported,3,4 but there 
have been no detailed clinical findings regarding the 
victims. Because the prognosis of myocarditis with 
CAVB remains unknown, the purpose of this study 
was to investigate the outcome of myocarditis with 
CAVB in our institution.
2. Materials and Methods
This is a retrospective study. Between June 1998 
and June 2007, nine pediatric patients who ful-
filled the clinical diagnosis of myocarditis with 
CAVB were enrolled. Myocarditis was diagnosed 
if there were clinical symptoms compatible with 
myocarditis and at least one of the following: ele-
vated cardiac enzyme (creatine kinase (CK) and CK 
MB isoenzyme (CKMB)), cardiomegaly by chest X-ray, 
or impaired heart contractility by echocardiogra-
phy. Patients with underlying congenital heart de-
fects, coronary artery anomalies, cardiomyopathy, 
collagen vascular disease, or who had received 
heart surgery were excluded. The indication for 
temporary pacemaker implantation was a persist-
ent ventricular rate < 60 beats/minute associated 
with hypotension or low cardiac output. The clinical 
presentations, biochemistry and serology studies, 
chest X-rays, electrocardiograms (EKG), echocardi-
ography, complications and outcomes were collected 
and analyzed.
In the study, hypotension was defined as systolic 
blood pressure < 5th percentile for age. Cardiomegaly 
of chest X-ray was defined as a cardio-thoracic ratio 
of ≥ 55%.
3. Results
The study included five boys and four girls, whose 
ages ranged from 1.5 to 16 years (mean 9.5 ± 4.2 
years). The baseline data and clinical presentations 
are presented in Table 1.
Seven patients had an antecedent history of 
fever, while four patients had associated respiratory 
tract infections. Three patients had chest pain. 
Five patients had gastrointestinal symptoms, such 
as abdominal pain, nausea or vomiting. Hypotension 
was noted in five (56%) patients and Stokes-Adams 
seizures in four (44%). Laboratory data are pre-
sented in Table 2. Two patients had total white 
blood cell counts greater than 12,000/mm3 and 
three patients had mild C-reactive protein eleva-
tion (> 5 mg/dL). The CK level was elevated in 
seven patients (> 150 U/L), but only two of them 
had abnormal CKMB/CK ratio (> 5%). Seven patients 
had abnormal liver function tests (AST and/or ALT), 
and two had impaired renal function. All patients 
returned to normal except the fatal patient, who 
had rapidly deteriorating liver and renal functions 
on the 4th day. One patient (case 2) suffered from 
severe hypotension and significant gastrointestinal 
symptoms. She was diagnosed as acute renal fail-
ure due to abnormal renal functions and the medi-
cal attendants initially considered hemodialysis. 
Her liver and heart functions were abnormal, too. 
However, after an effective pacemaker implanta-
tion and supportive treatment such as inotropic 
and antiarrythmic agents and O2, her cardiac, renal 
and hepatic functions completely returned to nor-
mal on the 5th day of admission without hemodial-
ysis. Throat and/or rectal swabs for virus isolation 
were performed in six of the cases, but no etiology 
was identified. The etiology of myocarditis was 
determined in two patients, including mycoplasma 
(1) and coxsackie B virus (1), with four-fold increased 
paired serology studies.
Table 1 Clinical presentations of patients of myocarditis with CAVB
Case  Age
   Stokes-  
Respiratory GI Chest
 Sex  Fever Hypotension Adams    Etiology
no.  (y/o)
   seizure  
symptoms symptoms* pain
1 M 7.8 +     + 
2 F 10.9 + +   +  Coxsackie B virus 
3 M 5.8 + + +    
4 F 15.6   +   + 
5 M 9.6 + + + + + + 
6 M 1.5 +   + +  
7 M 10 + +  + +  
8 F 13.4  +     
9 F 10.2 +  + + +  Mycoplasma
*Included abdominal pain, nausea or vomiting. GI = gastrointestinal.
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Eight patients had cardiomegaly on admission. 
The only patient who had a normal heart size (case 
5) died. Most of the cardiomegaly was mild and 
transient and the cardiomegaly completely subsided 
in all patients during follow-up. The initial ventricu-
lar rate of EKG was from 20 to 51 beats/minute 
whilst echocardiography revealed impaired left 
ventricular (LV) functions in three patients, and 
mitral regurgitation in eight patients (Table 3).
All patients had inotropic agents (dopamine or 
dobutamine) after admission. Two cases received 
intravenous immunoglobulin treatment (cases 6 
and 7). A transvenous temporary ventricular pacing 
catheter was inserted in seven patients, but not 
case 3, who had normal sinus rhythm after isopro-
terenol therapy, and not in case 6, who remained 
stable after admission. Mean recapture of atrioven-
tricular conduction began the 7th day after admission 
(range 1−12 days) in six patients. Two patients had 
persis tent CAVB; one patient (case 4) received a per-
manent pacemaker implantation on the 14th day, 
while the other (case 6) was observed clinically 
without a pacemaker implantation because of his 
adequate ventricular rate (> 60 beats/minute) with-
out hemodynamic instability.
Six patients suffered ventricular tachycardia 
(VT) after admission. VT occurred in three patients 
before and three after pacemaker implantation; 
two of them were related to isoproterenol therapy. 
All ventricular tachycardia subsided after lidocaine 
intravenous injection in four cases and lidocaine 
with discontinuation of isoproterenol therapy in 
the other two cases.
The only mortality case was a 9-year-old boy. 
He had normal LV performance (ejection fraction 
59%) and normal cardio-thoracic ratio by chest 
X-ray initially. However, progressive cardiomegaly, 
deteriorating LV function and progressive mitral 
regurgitation developed even after temporal pace-
maker implantation and inotropic agents. Unfortu-
nately, he died of persistent low cardiac output 
and a new onset VT on the 4th admission day.
Table 2 Laboratory characteristics of patients of myocarditis with CAVB
Case no. CKMB/CK (U/L) (%) BUN/Cr (mg/dL) AST/ALT (U/L) CRP (mg/L)  WBC (/mm3) CXR:CTR (%)
1 47.9/1020 (4.7) 9/0.5 91/ND 3.4 6000 61
2 47.1/3384 (1.4) 95/5 12624/ND 27.9 21,400 70
3 17/417 (4.1) 20/ND 75/ND 26.6 10,100 59
4 3.9/53 (7.4) 10/0.6 19/14 3.3 9600 58
5 219/1751 (12.5) 16/0.9 173/30 3.4 9300 54
6 7.8/77 (10.13) ND/ND 30/ND 5.0 7000 58
7 44/957 (4.6) 11/1.2 155/43 3.4 11,400 58
8 45.7/1121 (4.1) 16/0.8 171/51 11.4 5100 59
9 32/764 (4.2) 21/0.8 105/24 2.2 13,800 60
ALT = alanine aminotransferase; AST = aspartate aminotransferase; BUN = blood urea nitrogen; CK = creatine kinase; CKMB = 
creatine kinase MB isoenzyme; Cr = creatine; CRP = C-reactive protein; CTR = cardio-thoracic ratio; CXR = chest X-ray; ND = not 
done; WBC = white blood cell.
Table 3 Summary of clinical courses of patients of myocarditis with CAVB
 Duration of  Recapture   
Initial   Follow-up
Case no. hospitalization  sinus rhythm VT  MR  Result
 (days)  after PI (days)  
LVEF (%)  EKG
1 16 12  54 + NSR Survival
2 18  7 +* 18  NSR Survival
3  9  1 +† 65 + NSR Survival
4 14 No  58 + PR Survival‡
5  4 No +* 59 +  Expired
6 13 No  81 + CAVB Survival
7 13  9 +† 58 + RBBB Survival
8 13  5 +* 70 + RBBB Survival
9 15  7 +† 53 + RBBB Survival
*After pacemaker implantation; †before pacemaker implantation; ‡with permanent pacemaker. CAVB = complete atrioventricular 
block; EKG = electrocardiogram; LVEF = left ventricular ejection fraction; MR = mitral regurgitation; NSR = normal sinus rhythm; 
PI = pacemaker implantation; PR = pacemaker rhythm; RBBB = right bundle branch block; VT = ventricular tachycardia.
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During a follow-up period of 56 ± 27 months, 
all eight surviving patients were asymptomatic and 
medication-free. Six patients had normal sinus 
rhythm; two of them had right bundle branch block 
(RBBB). The remaining two patients had CAVB, and 
one received permanent pacemaker implantation.
4. Discussion
The symptoms and signs of acute myocarditis in 
children are usually nonspecific; therefore, early 
diagnosis is difficult in the early stages. For most of 
the cases, tachycardia is the first sign of myocarditis 
due to the compensation for congestive heart fail-
ure.6 However, for patients with myocarditis with 
CAVB, the heart rate is bradycardia instead of tachy-
cardia. Therefore, careful check of the patient’s 
heart rate can give an important clue for diagnosis 
of myocarditis with CAVB.
In our study, fever, gastrointestinal tract upset 
and respiratory tract infections were common but 
non-specific in myocarditis with CAVB. Only three 
patients referred to our institution had the impres-
sion of myocarditis, and the correct diagnoses were 
usually delayed, with a mean of 3 days (range, 1−5 
days) after the first symptoms appeared. Since fever 
and gastrointestinal tract upset usually accelerated 
a patient’s heart rate, bradycardia counter to the 
presence of these discomforts should alert us to 
suspect this diagnosis. Carefully evaluating the 
patient’s heart rate and performing a complete 
12-lead EKG study are the best noninvasive meth-
ods for the diagnosis of myocarditis with CAVB. 
Mahoney et al also stated that a Stokes-Adams sei-
zure may be the only clinical manifestation of myo-
carditis with CAVB.7 According to our experience, 
both hypotension and Stokes-Adams seizures were 
two more specific manifestations of myocarditis 
with CAVB.
Coxsackie virus infection is considered the most 
common etiology of acute viral myocarditis in chil-
dren. However, in myocarditis with CAVB, there was 
no coxsackie virus infection identified in Wang et al8 
and only one case in our study. This may partially 
explain why the clinical manifestations and out-
comes of myocarditis with tachycardia are differ-
ent from myocarditis with CAVB.
Cardiomegaly and/or pulmonary edema are com-
mon in patients with myocarditis, but it is rare in 
myocarditis complicated with CAVB. The suboptimal 
heart rate, secondary to advanced heart block, may 
lead to poor cardiac output before eventual develop-
ment of congestive heart failure and cardiomegaly.3 
Wang et al reported an incidence of 22% for cardi-
omegaly in children with myocarditis with CAVB.8 
In our study, cardiomegaly was more common, but 
it was not related to the severity of the disease for 
this group of patients.
Although the cardiac enzymes of CPK was 
elevated in most of our patients (7/9 cases), only 
three patients had a CKMB/CK ratio greater than 
5%. Those parameters returned rapidly to normal 
after temporary pacemaker implantation. The ini-
tial and peak levels did not relate to the long-term 
outcome of myocarditis, the same finding as in 
previous studies.9,10 Most patients with myocardi-
tis complicated with CAVB had conduction system 
inflammation involved predominantly and limited 
injury of the myocardial layers.11 Therefore, they 
preserve normal heart size and LV performance.12 
This may explain the relatively low incidence of the 
elevated CKMB/CK ratio.
In our study, all except one patient improved their 
symptoms and signs of low cardiac output within 
1−4 days after effective pacemaker implantation. 
A decreased cardiac output in children with myo-
carditis with CAVB carries a poor prognosis.13 One 
patient died on the 4th day. He had persistent low 
cardiac output even after pacemaker implantation 
and inotropic treatment. He developed multiple or-
gan failure due to progressive myocarditis. For most 
cases of myocarditis with CAVB, early transvenous 
pacemaker implantation is usually life-saving, but in 
this case, mortality happened even after pacemaker 
implantation. In such a situation, quickly establish-
ing extracorporeal membrane oxygenation therapy 
to maintain his cardiac output might have been 
crucial and should be considered the next time.
The common complications of myocarditis in-
clude cardiomyopathy, mitral regurgitation, VT, bun-
dle branch block or persistent CAVB. Data regarding 
the outcome of CAVB associated with myocarditis 
in children is limited. Wang et al reported nine 
children with CAVB, complicated with myocarditis.8 
All were in good long-term prognosis except one who 
had persistent CAVB, but became normal 3 years 
later. Chen et al found two pediatric patients re-
covered completely without pacemaker treatment.14 
Batra et al reviewed a total of 40 cases of children 
with myocarditis complicated by CAVB;5 27 patients 
(67.5%) recovered normal AV conduction, 11 pa-
tients (27.5%) had permanent pacemaker implan-
tation, and two patients (5%) died. In our study, 
two patients had persistent CAVB, and none had 
developed cardiomyopathy. Eight patients had mi-
tral regurgitation initially, and only two patients 
still had asymptomatic mitral regurgitation at the 
latest follow-up.
Six patients (67%) suffered a short course of 
VT. Myocarditis itself could cause the electrical 
instability. The therapeutic chronotropic agents that 
are used to increase the heart rate also promote 
arrhythmia. After the implantation of a pacemaker, 
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it is important to observe the possibility of VT for 
every episode of tachycardia. Under the pacing of 
a pacemaker, the heart rate should not be faster 
than the fixed setting rate, unless the patient has 
recaptured his natural rhythm, but that seldom oc-
curs on the 1st day. However, VT is most common on 
the first few days and needs to be treated immedi-
ately because it might induce severe hemodynamic 
compromise.15 Our fatal patient had unusual late 
onset of ventricular tachycardia 3 days after admis-
sion, even under the working percutaneous pace-
maker. The late onset of ventricular tachycardia 
might hint that the process of myocarditis is ongo-
ing or even exacerbated. In this case, his fragile 
heart could not tolerate further arrhythmia. It is 
mandatory to closely monitor and promptly stop the 
occurrence of VT because it might be an indicator of 
mortality if it attacks later or becomes prolonged.
In conclusion, the outcome of CAVB compli-
cated with myocarditis is variable. Most patients 
resume normal heart function after myocarditis 
with CAVB. The incidence of persistent CAVB in our 
study was 22%. VT was a common and serious com-
plication, but could be effectively treated medically. 
Persistent low cardiac output after pace maker im-
plantation in acute stage and late onset of VT 
should be considered as risk factors for mortality.
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